D-1535-2020 Class II Terminated

Recalled by Aurobindo Pharma USA Inc. — East Windsor, NJ

FDA drug recall D-1535-2020 was initiated by Aurobindo Pharma USA Inc. on Aug 10, 2020 and is designated Class II. Reason for recall: Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s). The recall status is terminated (terminated Jun 28, 2024). Affected quantity: 5748 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 2, 2020
Initiation Date
Aug 10, 2020
Termination Date
Jun 28, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5748 bottles

Product description

Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC: 65862-420-05.

Reason for recall

Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).

Distribution pattern

Nationwide in the U.S.

Code information

Lot #s: STSD19109-A, Exp. 05/31/2022; SP1D19083AA3, SP1D19084AA3, Exp. 08/31/2022.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1535-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1535-2020. Report a data issue: hello@regdatalab.com.